Cambrian Genomics

  • Uses massive parallel sequencing and laser catapulting methods to select and recover oligonucleotide sequences needed to build complete genes
  • Claims its process can synthesize genes for $0.03/bp to $0.05/bp, which is much lower than incumbent technologies
  • Plans to pursue model sim...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research

Cardea Bio

Company Profile | December 13, 2020

Offers graphene‑based lab‑on‑a‑chip biosensor systems, including biology‑gated graphene field‑effect transistors that allow for electronic chipsets built with molecular biology (e.g., integrating clustered regularly interspaced short palindromic repeats [CRISPR]), electronic devices, AI and ... To read more, click here.

Clear Labs

Company Snapshot | January 14, 2021

The company was started by Dr. Sasan Amini (Chief Executive Officer) and Mahni Ghorashi (former Chief Commercial Officer), both with experience in genomics testing. To date, the company has raised about $62 million, most recently from an $18 million round in May 2020. Among its investors, we ... To read more, click here.


Company Profile | April 06, 2022

Developer of DNAFoil, B3, and BEAMitup — rapid DNA tests for food authentication and compliance; intends to sell compliance‑as‑a‑service via BEAMitup and ISO17025 certificates Company utilizes library of 200,000 unique DNA fingerprints to create onsite DNA tests with results in 30 minutes ... Not part of subscription